Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-20-007972
Filing Date
2020-04-17
Accepted
2020-04-17 17:26:35
Documents
2
Period of Report
2020-06-17

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A dffn20200417_pre14a.htm PRE 14A 524337
2 logo.jpg GRAPHIC 22192
  Complete submission text file 0001437749-20-007972.txt   556345
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37942 | Film No.: 20800657
SIC: 2834 Pharmaceutical Preparations